CHRISTOPHER HORRELL: Open Payments
NPI 1134558885 · MT PLEASANT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 74 payments from 14 companies in 2025. Trend: 2023 $767 · 2024 $1,128 · 2025 $1,375
Food & beverage: $1,375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $373 |
| AstraZeneca Pharmaceuticals LP | 6 | $230 |
| Vanda Pharmaceuticals Inc. | 9 | $161 |
| Novo Nordisk Inc | 11 | $155 |
| GlaxoSmithKline, LLC. | 6 | $114 |
| Aimmune Therapeutics, Inc. | 4 | $77 |
| PFIZER INC. | 3 | $52 |
| Exact Sciences Corporation | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: QULIPTA, AIRSUPRA, FANAPT, VRAYLAR, TRELEGY ELLIPTA, ZENPEP, Rybelsus, BREZTRI.
Industry payments across PA — which companies pay providers there.
